131 related articles for article (PubMed ID: 12810241)
1. Risk factor management in stable, insulin-treated patients with Type 2 diabetes: the Diabetes Outcomes in Veterans Study.
Murata GH; Shah JH; Wendel CS; Hoffman RM; Adam KD; Bokhari SU; Solvas PA; Duckworth WC
J Diabetes Complications; 2003; 17(4):186-91. PubMed ID: 12810241
[TBL] [Abstract][Full Text] [Related]
2. Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes.
Abraira C; Colwell JA; Nuttall FQ; Sawin CT; Nagel NJ; Comstock JP; Emanuele NV; Levin SR; Henderson W; Lee HS
Diabetes Care; 1995 Aug; 18(8):1113-23. PubMed ID: 7587846
[TBL] [Abstract][Full Text] [Related]
3. Racial and ethnic disparities in the control of cardiovascular disease risk factors in Southwest American veterans with type 2 diabetes: the Diabetes Outcomes in Veterans Study.
Wendel CS; Shah JH; Duckworth WC; Hoffman RM; Mohler MJ; Murata GH
BMC Health Serv Res; 2006 May; 6():58. PubMed ID: 16716235
[TBL] [Abstract][Full Text] [Related]
4. Evaluating once- and twice-daily self-monitored blood glucose testing strategies for stable insulin-treated patients with type 2 diabetes : the diabetes outcomes in veterans study.
Hoffman RM; Shah JH; Wendel CS; Duckworth WC; Adam KD; Bokhari SU; Dalton C; Murata GH;
Diabetes Care; 2002 Oct; 25(10):1744-8. PubMed ID: 12351471
[TBL] [Abstract][Full Text] [Related]
5. Contributions of weekly mean blood glucose values to hemoglobin A1c in insulin-treated type 2 diabetes: the Diabetes Outcomes in Veterans Study (DOVES).
Murata GH; Hoffman RM; Duckworth WC; Wendel CS; Shah JH;
Am J Med Sci; 2004 Jun; 327(6):319-23. PubMed ID: 15201644
[TBL] [Abstract][Full Text] [Related]
6. Intensified blood glucose monitoring improves glycemic control in stable, insulin-treated veterans with type 2 diabetes: the Diabetes Outcomes in Veterans Study (DOVES).
Murata GH; Shah JH; Hoffman RM; Wendel CS; Adam KD; Solvas PA; Bokhari SU; Duckworth WC;
Diabetes Care; 2003 Jun; 26(6):1759-63. PubMed ID: 12766106
[TBL] [Abstract][Full Text] [Related]
7. Evaluations of retinopathy in the VA Cooperative Study on Glycemic Control and Complications in Type II Diabetes (VA CSDM). A feasibility study.
Emanuele N; Klein R; Abraira C; Colwell J; Comstock J; Henderson WG; Levin S; Nuttall F; Sawin C; Silbert C; Lee HS; Johnson-Nagel N
Diabetes Care; 1996 Dec; 19(12):1375-81. PubMed ID: 8941467
[TBL] [Abstract][Full Text] [Related]
8. Factors affecting hypoglycemia awareness in insulin-treated type 2 diabetes: The Diabetes Outcomes in Veterans Study (DOVES).
Murata GH; Duckworth WC; Shah JH; Wendel CS; Hoffman RM;
Diabetes Res Clin Pract; 2004 Jul; 65(1):61-7. PubMed ID: 15163479
[TBL] [Abstract][Full Text] [Related]
9. Design of the cooperative study on glycemic control and complications in diabetes mellitus type 2: Veterans Affairs Diabetes Trial.
Abraira C; Duckworth W; McCarren M; Emanuele N; Arca D; Reda D; Henderson W;
J Diabetes Complications; 2003; 17(6):314-22. PubMed ID: 14583175
[TBL] [Abstract][Full Text] [Related]
10. Glycaemic separation and risk factor control in the Veterans Affairs Diabetes Trial: an interim report.
Abraira C; Duckworth WC; Moritz T;
Diabetes Obes Metab; 2009 Feb; 11(2):150-6. PubMed ID: 18671796
[TBL] [Abstract][Full Text] [Related]
11. Response to intensive therapy steps and to glipizide dose in combination with insulin in type 2 diabetes. VA feasibility study on glycemic control and complications (VA CSDM).
Abraira C; Henderson WG; Colwell JA; Nuttall FQ; Comstock JP; Emanuele NV; Levin SR; Sawin CT; Silbert CK
Diabetes Care; 1998 Apr; 21(4):574-9. PubMed ID: 9571345
[TBL] [Abstract][Full Text] [Related]
12. Characterization of cardiovascular outcomes in a type 2 diabetes glucose supply and insulin demand model.
Monte SV; Schentag JJ; Adelman MH; Paladino JA
J Diabetes Sci Technol; 2010 Mar; 4(2):382-90. PubMed ID: 20307400
[TBL] [Abstract][Full Text] [Related]
13. Incidences of Severe Hypoglycemia and Diabetic Ketoacidosis and Prevalence of Microvascular Complications Stratified by Age and Glycemic Control in U.S. Adult Patients With Type 1 Diabetes: A Real-World Study.
Pettus JH; Zhou FL; Shepherd L; Preblick R; Hunt PR; Paranjape S; Miller KM; Edelman SV
Diabetes Care; 2019 Dec; 42(12):2220-2227. PubMed ID: 31548241
[TBL] [Abstract][Full Text] [Related]
14. Hypoglycemia in stable, insulin-treated veterans with type 2 diabetes: a prospective study of 1662 episodes.
Murata GH; Duckworth WC; Shah JH; Wendel CS; Mohler MJ; Hoffman RM
J Diabetes Complications; 2005; 19(1):10-7. PubMed ID: 15642485
[TBL] [Abstract][Full Text] [Related]
15. Correlation between baseline characteristics and clinical outcomes in a large population of diabetes patients treated with liraglutide in a real-world setting in Italy.
Lapolla A; Frison V; Bettio M; Dal Pos M; Rocchini P; Panebianco G; Tadiotto F; Da Tos V; D'Ambrosio M; Marangoni A; Ferrari M; Pianta A; Balzano S; Confortin L; Lamonica M; Marin N; Strazzabosco M; Brun E; Mesturino CA; Simoncini M; Zen F; Bax G; Bonsembiante B; Cardone C; Dal Frà MG; Gallo A; Masin M; Piarulli F; Sartore G; Simioni N
Clin Ther; 2015 Mar; 37(3):574-84. PubMed ID: 25626486
[TBL] [Abstract][Full Text] [Related]
16. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.
Lancet; 1998 Sep; 352(9131):837-53. PubMed ID: 9742976
[TBL] [Abstract][Full Text] [Related]
17. The feasibility of intensive insulin management in non-insulin-dependent diabetes mellitus. Implications of the Veterans Affairs Cooperative Study on Glycemic Control and Complications in NIDDM.
Colwell JA
Ann Intern Med; 1996 Jan; 124(1 Pt 2):131-5. PubMed ID: 8554205
[TBL] [Abstract][Full Text] [Related]
18. Glycemic control with Humalog Mix25 in type 2 diabetes inadequately controlled with glyburide.
Roach ; Koledova E; Metcalfe S; Hultman C; Milicevic Z;
Clin Ther; 2001 Oct; 23(10):1732-44. PubMed ID: 11726007
[TBL] [Abstract][Full Text] [Related]
19. Assessing potential glycemic overtreatment in persons at hypoglycemic risk.
Tseng CL; Soroka O; Maney M; Aron DC; Pogach LM
JAMA Intern Med; 2014 Feb; 174(2):259-68. PubMed ID: 24322626
[TBL] [Abstract][Full Text] [Related]
20. Baseline and 1-year interim follow-up assessment of Japanese patients initiating insulin therapy who were enrolled in the cardiovascular risk evaluation in people with type 2 diabetes on insulin therapy study: an international, multicenter, observational study.
Kawamori R; Node K; Hanafusa T; Atsumi Y; Naito Y; Oka Y
Cardiovasc Diabetol; 2013 Sep; 12():131. PubMed ID: 24011395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
